作者: Pedro D'orleans-Juste , Ghassan Bkaily , Joao B. Calixto , Rosendo A. Yunes
DOI:
关键词:
摘要: The present invention relates to Ca2+ channel blockers and more particularly the R-type blockers. More specifically, activity of Mandevilla velutina illustris. further concerns saponin-like compounds isolated from species. also treatment several pathologies that involve nifedipine-insensitive but isradipine sensitive steady-state use in these pathologies.